Mostrar el registro sencillo del ítem

dc.contributor.author
Barti, Benjámin  
dc.contributor.author
Dudok, Barna  
dc.contributor.author
Kenesei, Kata  
dc.contributor.author
Zöldi, Miklós  
dc.contributor.author
Miczán, Vivien  
dc.contributor.author
Balla, Gyula Y.  
dc.contributor.author
Zala, Diana  
dc.contributor.author
Tasso, Mariana Patricia  
dc.contributor.author
Sagheddu, Claudia  
dc.contributor.author
Kisfali, Máté  
dc.contributor.author
Tóth, Blanka  
dc.contributor.author
Ledri, Marco  
dc.contributor.author
Vizi, E. Sylvester  
dc.contributor.author
Melis, Miriam  
dc.contributor.author
Barna, László  
dc.contributor.author
Lenkei, Zsolt  
dc.contributor.author
Soltész, Iván  
dc.contributor.author
Katona, István  
dc.date.available
2024-07-16T12:08:35Z  
dc.date.issued
2024-05  
dc.identifier.citation
Barti, Benjámin; Dudok, Barna; Kenesei, Kata; Zöldi, Miklós; Miczán, Vivien; et al.; Presynaptic nanoscale components of retrograde synaptic signaling; Science Advances is the American Association for the Advancement of Science; Science Advances; 10; 22; 5-2024; 1-20  
dc.identifier.issn
2375-2548  
dc.identifier.uri
http://hdl.handle.net/11336/240036  
dc.description.abstract
While our understanding of the nanoscale architecture of anterograde synaptic transmission is rapidly expanding, the qualitative and quantitative molecular principles underlying distinct mechanisms of retrograde synaptic communication remain elusive. We show that a particular form of tonic cannabinoid signaling is essential for setting target cell–dependent synaptic variability. It does not require the activity of the two major endocannabinoid-producing enzymes. Instead, by developing a workflow for physiological, anatomical, and molecular measurements at the same unitary synapse, we demonstrate that the nanoscale stoichiometric ratio of type 1 cannabinoid receptors (CB1Rs) to the release machinery is sufficient to predict synapse-specific release probability. Accordingly, selective decrease of extrasynaptic CB1Rs does not affect synaptic transmission, whereas in vivo exposure to the phytocannabinoid Δ9-tetrahydrocannabinol disrupts the intrasynaptic nanoscale stoichiometry and reduces synaptic variability. These findings imply that synapses leverage the nanoscale stoichiometry of presynaptic receptor coupling to the release machinery to establish synaptic strength in a target cell–dependent manner.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Science Advances is the American Association for the Advancement of Science  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc/2.5/ar/  
dc.subject
CB1 receptor  
dc.subject
Presynaptic component  
dc.subject.classification
Bioquímica y Biología Molecular  
dc.subject.classification
Ciencias Biológicas  
dc.subject.classification
CIENCIAS NATURALES Y EXACTAS  
dc.title
Presynaptic nanoscale components of retrograde synaptic signaling  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2024-06-24T10:09:03Z  
dc.journal.volume
10  
dc.journal.number
22  
dc.journal.pagination
1-20  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Washington D.C  
dc.description.fil
Fil: Barti, Benjámin. Indiana University; Estados Unidos. Semmelweis University; Hungría. HUN-REN Institute of Experimental Medicine; Hungría  
dc.description.fil
Fil: Dudok, Barna. HUN-REN Institute of Experimental Medicine; Hungría. Baylor College of Medicine; Estados Unidos. University of Stanford; Estados Unidos  
dc.description.fil
Fil: Kenesei, Kata. HUN-REN Institute of Experimental Medicine; Hungría  
dc.description.fil
Fil: Zöldi, Miklós. Indiana University; Estados Unidos. HUN-REN Institute of Experimental Medicine; Hungría. Semmelweis University; Hungría  
dc.description.fil
Fil: Miczán, Vivien. HUN-REN Institute of Experimental Medicine; Hungría. HUN-REN Biological Research Center; Hungría  
dc.description.fil
Fil: Balla, Gyula Y.. HUN-REN Institute of Experimental Medicine; Hungría. Semmelweis University; Hungría  
dc.description.fil
Fil: Zala, Diana. Inserm; Francia  
dc.description.fil
Fil: Tasso, Mariana Patricia. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. Universidad Nacional de San Martin. Instituto de Nanosistemas; Argentina  
dc.description.fil
Fil: Sagheddu, Claudia. Università Degli Studi Di Cagliari.; Italia  
dc.description.fil
Fil: Kisfali, Máté. HUN-REN Institute of Experimental Medicine; Hungría. BiTrial Ltd.; Hungría  
dc.description.fil
Fil: Tóth, Blanka. Budapest University of Technology and Economics; Hungría. Semmelweis University; Hungría  
dc.description.fil
Fil: Ledri, Marco. HUN-REN Institute of Experimental Medicine; Hungría. Lund University; Suecia  
dc.description.fil
Fil: Vizi, E. Sylvester. HUN-REN Institute of Experimental Medicine; Hungría  
dc.description.fil
Fil: Melis, Miriam. Università Degli Studi Di Cagliari.; Italia  
dc.description.fil
Fil: Barna, László. Indiana University; Estados Unidos  
dc.description.fil
Fil: Lenkei, Zsolt. Inserm; Francia  
dc.description.fil
Fil: Soltész, Iván. University of Stanford; Estados Unidos  
dc.description.fil
Fil: Katona, István. Indiana University; Estados Unidos. HUN-REN Institute of Experimental Medicine; Hungría  
dc.journal.title
Science Advances  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.science.org/doi/10.1126/sciadv.ado0077  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/https://doi.org/10.1126/sciadv.ado0077